MAUDE MDR 3518826

MDR report key
3518826
Report number
1018233-2013-09562
Event key
0
Event type
3
Date received
2013-11-27
Adverse event
3
Product problem
3
Patients in event
0
Reporter occupation
600
Health professional
3
Initial report to FDA
3
Event location
3

Manufacturer Contact#

Contact
LISA HALL
Address
8195 INDUSTRIAL BLVD COVINGTON GA 30014 US
Phone
770-770-7707
Report source
M
Manufacturer link flag
Y

Devices#

Seq, Brand, Generic table
SeqBrandGenericManufacturerProduct codeModelCatalogLotPMA510(k)ImplantEvaluatedAvailability
1AVAULTA SOLO SYNTHETIC SUPPORT SYSTEM ANTERIORBARD SHANNON LIMITED -3005636544OTPNA486100HUTF2232R N

Patients#

Sequence, Received, Treatment table
SequenceReceivedTreatmentOutcome
12013-11-2701. R

Event Narratives#

D

Patient 1

THE PATIENT'S ATTORNEY ALLEGED A DEFICIENCY AGAINST THE DEVICE. PER ADD'L INFO REC'D, THE PATIENT HAS EXPERIENCED PAIN, EXTRUSION, INFECTION, URINARY PROBLEMS, BOWEL PROBLEMS, RECURRENCE, DYSPAREUNIA, AND NEUROMUSCULAR PROBLEMS.

N

Patient 1

THE SAMPLE WAS NOT RETURNED. THE FINISHED PRODUCT MET ALL SPECIFICATIONS PRIOR TO BEING RELEASED FOR GENERAL DISTRIBUTION. THE INSTRUCTIONS FOR USE WHICH ACCOMPANIES ALL DEVICES CURRENTLY ADDRESSES POTENTIAL RISKS ASSOCIATED WITH SURGICALLY IMPLANTED MATERIALS. (B)(4).

N

Patient 1

THE SAMPLE WAS NOT RETURNED. THE FINISHED PRODUCT MET ALL SPECIFICATIONS PRIOR TO BEING RELEASED FOR GENERAL DISTRIBUTION. THE INSTRUCTIONS FOR USE WHICH ACCOMPANIES ALL DEVICES CURRENTLY ADDRESSES POTENTIAL RISKS ASSOCIATED WITH SURGICALLY IMPLANTED MATERIALS. THE INSTRUCTIONS FOR USE STATES IN THE ADVERSE EVENTS: POTENTIAL ADVERSE REACTIONS ARE THOSE TYPICALLY ASSOCIATED WITH SURGICALLY IMPLANTABLE MATERIALS, INCLUDING HEMATOMA, SEROMA, MUCOSAL OR VISCERAL EROSION, INFECTION, INFLAMMATION, SENSITIZATION, DYSPAREUNIA, SCARIFICATION AND CONTRACTION, FISTULA FORMATION, EXTRUSION AND RECURRENCE OF VAGINAL WALL PROLAPSE. PERFORATIONS OR LACERATIONS OF VESSELS, NERVES, BLADDER, BOWEL, RECTUM, OR ANY VISCERA MAY OCCUR DURING NEEDLE PASSAGE. (B)(4). THE INFORMATION PROVIDED BY BARD REPRESENTS ALL OF THE KNOWN INFORMATION AT THIS TIME. DESPITE GOOD FAITH EFFORTS TO OBTAIN ADDITIONAL INFORMATION, THE COMPLAINANT / REPORTER WAS UNABLE OR UNWILLING TO PROVIDE ANY FURTHER PATIENT, PRODUCT, OR PROCEDURAL DETAILS TO BARD.

D

Patient 1

PER ADDITIONAL INFORMATION RECEIVED, THE PATIENT HAS EXPERIENCED VAGINAL NERVE PAIN, LOW BACK PAIN, MIXED, URGE, STRESS URINARY INCONTINENCE, CONSTIPATION, PROLAPSE, LEFT HIP, LEG PAIN, SENSATION OF CRAWLING, USED WALKER (AMBULATION DIFFICULTIES), DISCOMFORT, LEG CRAMPS, DIZZINESS, NIGHT PAIN, LEUKOCYTES IN URINE, URGENCY, FREQUENCY, URINE LEAKAGE, NOCTURIA, ENURESIS, HESITANCY, URINARY TRACT INFECTIONS, DEFECATORY DYSFUNCTION, DOESN'T HAVE STRONG SENSATION OF RECTAL PRESSURE, STRAINS WITH BOWEL MOVEMENTS, SENSATION OF INCOMPLETE EVACUATION, USED DIGITAL MANEUVERS TO ASSIST WITH EVACUATION, ATROPHIC EXTERNAL GENITALIA, URETHROVESICAL JUNCTION HYPERMOBILITY, ATROPHIC VAGINA, SCAR TISSUE, NOCTURNAL ENURESIS, DETRUSOR OVERACTIVITY, URETHRAL HYPERMOBILITY, POLYURIA, EXCESSIVE URINE PRODUCTION, CHEST PAIN, SLEEP APNEA, B COMPLEX DEFICIENCIES, CHRONIC PAIN SYNDROME, MYALGIA, MYOSITIS (INFLAMMATION), VITAMIN D DEFICIENCY, DIARRHEA, MONONEURITIS, INSOMNIA (SLEEP DISTURBANCES), CONTUSION (BRUISE), IRON DEFICIENCY ANEMIA, DIZZINESS, EDEMA, HEADACHES, CARDIAC DYSRHYTHMIA AND NONSURGICAL INTERVENTIONS.